Compile Data Set for Download or QSAR
maximum 50k data
Found 69 Enz. Inhib. hit(s) with Target = 'Adenosine receptor A3 [I248L]'
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191046(US9181253, 109)
Affinity DataKi:  5.90nM ΔG°:  -47.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191068(US9181253, 115)
Affinity DataKi:  6.60nM ΔG°:  -46.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191057(US9181253, 119)
Affinity DataKi:  8.90nM ΔG°:  -46.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191061(US9181253, 123)
Affinity DataKi:  10.3nM ΔG°:  -45.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191055(US9181253, 117)
Affinity DataKi:  12nM ΔG°:  -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191045(US9181253, 108)
Affinity DataKi:  12.1nM ΔG°:  -45.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191062(US9181253, 124)
Affinity DataKi:  15.2nM ΔG°:  -44.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191064(US9181253, 126)
Affinity DataKi:  16.5nM ΔG°:  -44.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191069(US9181253, 116)
Affinity DataKi:  32.4nM ΔG°:  -42.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191066(US9181253, 128)
Affinity DataKi:  40.4nM ΔG°:  -42.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191060(US9181253, 122)
Affinity DataKi:  41.5nM ΔG°:  -42.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191056(US9181253, 118)
Affinity DataKi:  52nM ΔG°:  -41.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191065(US9181253, 127)
Affinity DataKi:  83.2nM ΔG°:  -40.4kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191058(US9181253, 120c)
Affinity DataKi:  110nM ΔG°:  -39.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191063(US9181253, 125)
Affinity DataKi:  114nM ΔG°:  -39.6kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191067(US9181253, 107)
Affinity DataKi:  160nM ΔG°:  -38.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191054(US9181253, 114)
Affinity DataKi:  236nM ΔG°:  -37.8kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191053(US9181253, 113)
Affinity DataKi:  315nM ΔG°:  -37.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191059(US9181253, 121)
Affinity DataKi:  470nM ΔG°:  -36.1kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191050(US9181253, 110)
Affinity DataKi:  500nM ΔG°:  -36.0kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191051(US9181253, 111)
Affinity DataKi:  560nM ΔG°:  -35.7kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175399(1,3-Dimethyl-8-[{3-(2-(hexamethyleneimin-1-yl)-2-o...)
Affinity DataKi:  797nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM191052(US9181253, 112)
Affinity DataKi:  1.53E+3nM ΔG°:  -33.2kJ/molepH: 7.5 T: 2°CAssay Description:Radioligand binding assays at A1, A2A, and A3ARs were performed according to the procedures described previously. Each tube in the binding assay cont...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175398(1,3-Dimethyl-8-[4-methoxy-3-{2-(piperidin-1-yl)-2-...)
Affinity DataKi:  1.97E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175381(1,3-Dimethyl-8-[3-{2-(hexamethyleneimin-1-yl)-2-ox...)
Affinity DataKi:  3.69E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175365(1,3-Dimethyl-8-[3-(2-methoxy-2-oxoethoxy)-phenyl]x...)
Affinity DataKi:  3.81E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175402(1,3-Dimethyl-8-[{3-(2-(imidazol-1-yl)-2-oxoethoxy)...)
Affinity DataKi:  4.10E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175372(1,3-Dimethyl-8-[4-{2-(hexamethyleneimin-1-yl)-2-ox...)
Affinity DataKi:  4.15E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175380(1,3-Dimethyl-8-[3-{2-(piperidin-1-yl)]-2-oxoethoxy...)
Affinity DataKi:  4.16E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175379(1,3-Dimethyl-8-[3-{2-(pyrrolidin-1-yl)-2-oxoethoxy...)
Affinity DataKi:  4.64E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175384(1,3-Dimethyl-8-[3-{2-(imidazol-1-yl)-2-oxoethoxy}-...)
Affinity DataKi:  4.89E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175383(1,3-Dimethyl-8-[3-{2-(1-methylpiperazin-4-yl)-2-ox...)
Affinity DataKi:  5.67E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175370(1,3-Dimethyl-8-[4-{2-(pyrrolidin-1-yl)-2-oxoethoxy...)
Affinity DataKi:  5.68E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175364(1,3-Dimethyl-8-[4-(2-methoxy-2-oxoethoxy)-phenyl]x...)
Affinity DataKi:  5.86E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175376(1,3-Dimethyl-8-[4-{2-(homoveratrylamino)-2-oxoetho...)
Affinity DataKi:  6.00E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175373(1,3-Dimethyl-8-[4-{2-(morpholin-1-yl)-2-oxoethoxy}...)
Affinity DataKi:  7.11E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175382(1,3-Dimethyl-8-[3-{2-(morpholin-1-yl)-2-oxoethoxy}...)
Affinity DataKi:  7.90E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175369(8-[4-{2-(Diethylaminoethylamino)-2-oxoethoxy}-phen...)
Affinity DataKi:  8.35E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175378(8-[3-{2-(Diethylaminoethylamino)-2-oxoethoxy}-phen...)
Affinity DataKi:  8.39E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175377(1,3-Dimethyl-8-[3-{2-(dimethylaminoethylamino)-2-o...)
Affinity DataKi:  8.97E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175397(1,3-Dimethyl-8-[4-methoxy-3-{2-(pyrrolidin-1-yl)-2...)
Affinity DataKi:  8.98E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175390(1,3-Dimethyl-8-[{4-(2-(hexamethyleneimin-1-yl)-2-o...)
Affinity DataKi:  9.01E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175385(1,3-Dimethyl-8-[3-{2-(homoveratrylamino)-2-oxoetho...)
Affinity DataKi:  9.25E+3nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175386(1,3-Dimethyl-8-[{4-(2-(dimethylaminoethylamino)-2-...)
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175401(1,3-Dimethyl-8-[4-methoxy-3-{2-(1-methylpiperazin-...)
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175389(1,3-Dimethyl-8-[3-methoxy-4-{2-(piperidin-1-yl)-2-...)
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175366(1,3-Dimethyl-8-[{4-(2-methoxy-2-oxoethoxy)-3-metho...)
Affinity DataKi: >1.00E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175374(1,3-Dimethyl-8-[4-{2-(1-methylpiperazin-4-yl)-2-ox...)
Affinity DataKi:  1.01E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175368(1,3-Dimethyl-8-[4-{2-(dimethylaminoethylamino)-2-o...)
Affinity DataKi:  1.05E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAdenosine receptor A3 [I248L](Homo sapiens (Human))
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services

US Patent
LigandPNGBDBM175367(1,3-Dimethyl-8-[{3-(2-methoxy-2-oxoethoxy)-4-metho...)
Affinity DataKi:  1.07E+4nMAssay Description:Dissociation constants at A1, A2A and A3 receptors (Ki-values) were determined in radioligand competition experiments as reported earlier [19,20]. Al...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 69 total ) | Next | Last >>
Jump to: